NEW YORK (GenomeWeb) – Life science and diagnostics company Meridian Bioscience reported before the opening of the market on Thursday that its second quarter revenues fell 1 percent, due to a decline in sales for its diagnostics segment.

For the three months ended March 31, the firm reported revenues of $51.3 million compared to revenues of $51.5 million in Q2 2015. Wall Street analysts had expected revenues of $52.1 million for the quarter.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Science speaks with the University of Michigan's Jedidiah Carlson, who has tracked population genetic discussions at white nationalist sites.

Gene therapies could qualify for a faster US Food and Drug Administration approval process, according to Stat News.

NPR reports that the US House of Representatives has passed a bill to enable terminally ill patients access to experimental drugs.

In Genome Research this week: inversion variants mapped in human, non-human primate genomes; transcriptome profiling of maize, sorghum; and more.